Clinical Trial Update: High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate Cancer [NA]

View source ↗

Summary

ClinicalTrials.gov entry for a study evaluating high-dose brachytherapy boost with stereotactic body radiation therapy for intermediate- or higher-risk prostate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University of Nebraska | Conditions: Prostatic Cancer | NA | Status: RECRUITING